POA Pharma was on the market March 2011. POA Pharma has offices and marketing organisations in the four Nordic Countries. Central Marketing & Development: POA Pharma develop products for treatment of Inborn Error of Metabolism. The products is classified as “Food for Special Medical Purposes Tactical POA works within nine areas of competence. POA Pharma management has more than 150 years of collective experience in marketing diagnostics, nutrition, pharmaceuticals and OTC products.
POA Pharma is now a Galen company
Galen, the privately owned global pharmaceutical sales and marketing company, is delighted to announce the acquisition and takeover of boutique healthcare company, POA Pharma.
New website coming soon